North America Travel Vaccines Market Growth and Business Opportunity By 2024
- Nikhil Kapoor
- Apr 10, 2020
- 2 min read
According to the latest report by IMARC Group titled, “North America Travel Vaccines Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, The North America travel vaccines market growth reached a value of US$ 2.4 Billion in 2018. Travel vaccines provide immunization to travelers, and they assist in reducing the risk of getting sick while traveling abroad. They are vaccinated four to six weeks before the journey to prevent the risk of developing certain diseases that can be caused due to the intake of contaminated food or water. These vaccines are usually recommended by health organizations based on the gender, age and medical history of the tourist. Looking forward, IMARC Group expects the market to reach a value of US$ 3.3 Billion by 2024, registering a CAGR of 5.3% during 2019-2024.
Request for a free sample copy of this report: https://www.imarcgroup.com/north-america-travel-vaccines-market
Several factors are currently driving the market for travel vaccines in the North American region. For instance, some of the prominent companies in the region are offering a wide range of travel vaccines, including a vaccine against varicella. They are also introducing innovative novel vaccines for preventing the re-emergence of infectious diseases in the region. Furthermore, the Centers for Disease Control and Prevention (CDC), a US-based federal agency, is offering important travel health updates to travelers on their websites, which enables them to locate the nearest travel clinic and the vaccination required according to the travel destination. This is expected to strengthen the market growth in the coming years. Buy full report with table of contents: https://www.imarcgroup.com/north-america-travel-vaccines-market Key Market Segmentation: Breakup by Region: 1. United States 2. Canada 3. Mexico Breakup by Composition: 1. Mono Vaccines 2. Combination Vaccines Breakup by Disease: 1. Hepatitis A 2. DPT 3. Yellow Fever 4. Typhoid 5. Hepatitis B 6. Measles and Mumps 7. Rabies 8. Meningococcal 9. Varicella 10. Japanese Encephalitis 11. Others Competitive Landscape: The report has also examined the competitive landscape of North America Travel Vaccines Market. Key highlights of the report: • Market Performance • Market Outlook • Porter’s Five Forces Analysis • Market Drivers and Success Factors • SWOT Analysis • Value Chain • Competitive Structure • Profiles of Key Players
Browse More Research Reports By IMARC Group:
About Us: IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. Contact US: IMARC Group 30 N Gould St, Ste R Sheridan, WY 82801, USA Website: https://www.imarcgroup.com/ Email: sales@imarcgroup.com USA: +1-631-791-1145 Follow us on twitter: @imarcglobal Linkedin: https://www.linkedin.com/company/imarc-group
Opmerkingen